BioServices: Marketplace for service providers in the pharmaceuticals and biotech industry
“Speed Dating” to increase networking effectiveness
There will also be a daily “Speed Dating” session for streamlined networking between representatives of biotech and pharmaceuticals companies and providers of services and solutions from the commercial and academic sectors. This is an important offering, because networking and partnership are crucial to new drug research and development in the biotech and pharmaceuticals sector. In many cases, drug companies don’t possess all the technical expertise needed to develop new drugs, and so it makes sense for them to outsource certain development, testing, approval and production tasks to external providers. This partnership model is also an effective way of managing risk and minimizing costs.
The marketplace character of the BioServices section of BIOTECHNICA 2013 makes it easy for potential customers to find the service providers they are looking for. Companies can also participate as exhibitors and further boost their profile by giving presentations at the lecture forum.
Other news from the department business & finance
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous